Reviewing NewGenIvf Group (NASDAQ:NIVF) & Fresenius Medical Care (NYSE:FMS)

NewGenIvf Group (NASDAQ:NIVF) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Valuation and Earnings

This table compares NewGenIvf Group and Fresenius Medical Care”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$5.14 million	0.59	$130,000.00	N/A	N/A
Fresenius Medical Care	$19.42 billion	0.59	$540.07 million	$0.89	21.96

Fresenius Medical Care has higher revenue and earnings than NewGenIvf Group.

Risk & Volatility

NewGenIvf Group has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for NewGenIvf Group and Fresenius Medical Care, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	0	0	0	0	N/A
Fresenius Medical Care	1	2	1	0	2.00

Fresenius Medical Care has a consensus price target of $23.00, indicating a potential upside of 17.71%. Given Fresenius Medical Care’s higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than NewGenIvf Group.

Profitability

This table compares NewGenIvf Group and Fresenius Medical Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Fresenius Medical Care	2.72%	5.48%	2.41%

Insider & Institutional Ownership

66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Fresenius Medical Care beats NewGenIvf Group on 9 of the 11 factors compared between the two stocks.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.